Search Results - "Cruzado, J. M"

Refine Results
  1. 1

    Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft Loss by Moreso, F., Ibernon, M., Gomà, M., Carrera, M., Fulladosa, X., Hueso, M., Gil‐Vernet, S., Cruzado, J. M., Torras, J., Grinyó, J. M., Serón, D.

    Published in American journal of transplantation (01-04-2006)
    “…Chronic allograft nephropathy (CAN) in protocol biopsies is associated with graft loss while the association between subclinical rejection (SCR) and outcome…”
    Get full text
    Journal Article
  2. 2

    Pretransplant Immediately Early‐1‐Specific T Cell Responses Provide Protection for CMV Infection After Kidney Transplantation by Bestard, O., Lucia, M., Crespo, E., Van Liempt, B., Palacio, D., Melilli, E., Torras, J., Llaudó, I., Cerezo, G., Taco, O., Gil‐Vernet, S., Grinyó, J. M., Cruzado, J. M.

    Published in American journal of transplantation (01-07-2013)
    “…Cytomegalovirus (CMV) infection is still a major complication after kidney transplantation. Although cytotoxic CMV‐specific T cells play a crucial role…”
    Get full text
    Journal Article
  3. 3

    Contribution of Population Pharmacokinetics to Dose Optimization of Ganciclovir-Valganciclovir in Solid-Organ Transplant Patients by Padullés, A, Colom, H, Bestard, O, Melilli, E, Sabé, N, Rigo, R, Niubó, J, Torras, J, Lladó, L, Manito, N, Caldés, A, Cruzado, J M, Grinyó, J M, Lloberas, N

    Published in Antimicrobial agents and chemotherapy (01-04-2016)
    “…Treatment of solid-organ transplant (SOT) patients with ganciclovir (GCV)-valganciclovir (VGCV) according to the manufacturer's recommendations may result in…”
    Get full text
    Journal Article
  4. 4

    Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes by Flaquer, M., Franquesa, M., Vidal, A., Bolaños, N., Torras, J., Lloberas, N., Herrero-Fresneda, I., Grinyó, J. M., Cruzado, J. M.

    Published in Diabetologia (01-07-2012)
    “…Aims/hypothesis We previously demonstrated hepatocyte growth factor (HGF) gene therapy was able to induce regression of glomerulosclerosis in diabetic…”
    Get full text
    Journal Article
  5. 5

    Cross‐Validation of IFN‐γ Elispot Assay for Measuring Alloreactive Memory/Effector T Cell Responses in Renal Transplant Recipients by Bestard, O., Crespo, E., Stein, M., Lúcia, M., Roelen, D. L., de Vaal, Y. J., Hernandez‐Fuentes, M. P., Chatenoud, L., Wood, K. J., Claas, F. H., Cruzado, J. M., Grinyó, J. M., Volk, H. D., Reinke, P.

    Published in American journal of transplantation (01-07-2013)
    “…Assessment of donor‐specific alloreactive memory/effector T cell responses using an IFN‐γ Elispot assay has been suggested to be a novel immune‐monitoring tool…”
    Get full text
    Journal Article
  6. 6

    Intragraft Regulatory T Cells in Protocol Biopsies Retain Foxp3 Demethylation and Are Protective Biomarkers for Kidney Graft Outcome by Bestard, O., Cuñetti, L., Cruzado, J. M., Lucia, M., Valdez, R., Olek, S., Melilli, E., Torras, J., Mast, R., Gomà, M., Franquesa, M., Grinyó, J. M.

    Published in American journal of transplantation (01-10-2011)
    “…Presence of subclinical rejection (SCR) with IF/TA in protocol biopsies of renal allografts has been shown to be an independent predictor factor of graft loss…”
    Get full text
    Journal Article
  7. 7

    Long‐Term Results of Biopsy‐Guided Selection and Allocation of Kidneys From Older Donors in Older Recipients by Fernández‐Lorente, L., Riera, L., Bestard, O., Carrera, M., Gomà, M., Porta, N., Torras, J., Melilli, E., Gil‐Vernet, S., Grinyó, J. M., Cruzado, J. M.

    Published in American journal of transplantation (01-10-2012)
    “…In our old‐for‐old program, we discard or allocate older extended criteria donor kidneys to single (SKT) or dual kidney transplantation (DKT) depending on…”
    Get full text
    Journal Article
  8. 8

    Clinical Features and Outcomes of Tuberculosis in Solid Organ Transplant Recipients by Bodro, M, Sabé, N, Santín, M, Cruzado, J.M, Lladó, L, González-Costello, J, Carratalà, J

    Published in Transplantation proceedings (01-11-2012)
    “…Abstract Background Tuberculosis (TB) remains a significant opportunistic infection in solid organ transplant (SOT) recipients. Moreover, its optimal treatment…”
    Get full text
    Journal Article Conference Proceeding
  9. 9
  10. 10

    Association of ANRIL gene polymorphisms with major adverse cardiovascular events in hemodialysis patients by Arbiol-Roca, A, Padró-Miquel, A, Hueso, M, Navarro, E, Alía-Ramos, P, González-Álvarez, MT, Rama, I, Torras, J, Grinyó, JM, Cruzado, JM, Lloberas, N

    Published in Clinica chimica acta (01-03-2017)
    “…Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD). Single nucleotide polymorphisms (SNPs) in ANRIL gene have…”
    Get full text
    Journal Article
  11. 11

    In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection by Ripoll, E, Pluvinet, R, Torras, J, Olivar, R, Vidal, A, Franquesa, M, Cassis, L, Cruzado, J M, Bestard, O, Grinyó, J M, Aran, J M, Herrero-Fresneda, I

    Published in Gene therapy (01-10-2011)
    “…The humoral branch of the immune response has an important role in acute and chronic allograft dysfunction. The CD40/CD40L costimulatory pathway is crucial in…”
    Get full text
    Journal Article
  12. 12

    Mycophenolate Mofetil and Sirolimus Combination in Renal Transplantation by Grinyó, J. M., Cruzado, J. M.

    Published in American journal of transplantation (01-09-2006)
    “…Mycophenolate mofetil (MMF) and sirolimus (SRL) are potent non‐nephrotoxic xenobiotic immunosuppressants. Their complementary properties may provide the…”
    Get full text
    Journal Article
  13. 13

    Successful outcome of ganciclovir-resistant cytomegalovirus infection in organ transplant recipients after conversion to mTOR inhibitors by Sabé, N, González-Costello, J, Rama, I, Niubó, J, Bodro, M, Roca, J, Cruzado, J M, Manito, N, Carratalà, J

    Published in Transplant international (01-07-2012)
    “…Ganciclovir-resistant (GanR) cytomegalovirus (CMV) infection after organ transplantation is emerging as a significant therapeutic challenge. We report two…”
    Get more information
    Journal Article
  14. 14

    Sterile Leukocyturia Is Associated With Interstitial Fibrosis and Tubular Atrophy in Kidney Allograft Protocol Biopsies by Coelho, S., Ortíz, F., Gelpi, R., Koskinen, P., Porta, N., Bestard, O., Melilli, E., Taco, O., Torras, J., Honkanen, E., Grinyó, J. M., Cruzado, J. M.

    Published in American journal of transplantation (01-04-2014)
    “…Kidney allograft interstitial fibrosis and tubular atrophy (IF/TA) is associated with a poorer renal function and outcome. In the current clinical practice, an…”
    Get full text
    Journal Article
  15. 15

    Revisiting Double Kidney Transplantation: Two Kidneys Provide Better Graft Survival Than One by Cruzado, J.M, Fernandez, L, Riera, L, Bestard, O, Carrera, M, Torras, J, Vernet, S. Gil, Melilli, E, Ngango, L, Grinyó, J.M

    Published in Transplantation proceedings (01-07-2011)
    “…Abstract Double kidney transplantation is an accepted strategy to increase the donor pool. Regarding older donor kidneys, protocols for deciding to perform a…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Immunephenotype of Glomerular and Interstitial Infiltrating Cells in Protocol Renal Allograft Biopsies and Histological Diagnosis by Moreso, F., Seron, D., O'Valle, F., Ibernon, M., Gomà, M., Hueso, M., Cruzado, J. M., Bestard, O., Duarte, V., García del Moral, R., Grinyó, J. M.

    Published in American journal of transplantation (01-12-2007)
    “…Patients with a protocol renal allograft biopsy simultaneously displaying interstitial fibrosis/tubular atrophy (IF/TA) and subclinical rejection (SCR) have a…”
    Get full text
    Journal Article
  17. 17

    Successful Renal Transplantation in a Patient with Atypical Hemolytic Uremic Syndrome Carrying Mutations in Both Factor I and MCP by Cruzado, J. M., De Córdoba, S. Rodríguez, Melilli, E., Bestard, O., Rama, I., Sánchez‐Corral, P., López‐Trascasa, M., Navarro, I., Torras, J., Gomà, M., Grinyó, J. M.

    Published in American journal of transplantation (01-06-2009)
    “…Kidney transplantation in patients with atypical hemolytic uremic syndrome (aHUS) carrying mutations in the soluble complement regulators factor H (CFH) or…”
    Get full text
    Journal Article
  18. 18

    Therapy With Plasmapheresis and Intravenous Immunoglobulin for Acute Humoral Rejection in Kidney Transplantation by Ibernón, M., Gil-Vernet, S., Carrera, M., Serón, D., Moreso, F., Bestard, O., Cruzado, J.M., Grinyó, J.M.

    Published in Transplantation proceedings (01-11-2005)
    “…Acute humoral rejection (AHR) is characterized by acute graft dysfunction associated with de novo production of donor-specific alloantibodies (DSA) and C4d…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    Direct electrotransfer of hHGF gene into kidney ameliorates ischemic acute renal failure by FRANQUESA, M, ALPEROVICH, G, HERRERO-FRESNEDA, I, LLOBERAS, N, BOLANOS, N, FILLAT, C, RAMA, I, CRUZADO, J. M, GRINYO, J. M, TORRAS, J

    Published in Gene therapy (01-11-2005)
    “…In the early phase of kidney transplantation, the transplanted kidney is exposed to insults like ischemia/reperfusion, which is a leading cause of acute renal…”
    Get full text
    Journal Article
  20. 20

    New immunosuppresor strategies in the treatment of murine lupus nephritis by Alperovich, G, Rama, I, Lloberas, N, Franquesa, M, Poveda, R, Gomà, M, Herrero-Fresneda, I, Cruzado, J M, Bolaños, N, Carrera, M, Grinyó, J M, Torras, J

    Published in Lupus (01-01-2007)
    “…Renal involvement in systemic lupus erythematosus is a common complication that significantly worsens morbidity and mortality. Although treatment with…”
    Get full text
    Journal Article